MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT

The review takes into consideration the novel data on heart failure treatment: application of mineralocorticoid antagonists. The pathogenetic points are highlighted that are proved by clinical trials, as epidemiological concerns. Further opportunites are sketched for this special kind of treatment b...

Full description

Bibliographic Details
Main Authors: V. N. Soboleva, E. O. Taratukhin
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2015-01-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/212
_version_ 1826561396872052736
author V. N. Soboleva
E. O. Taratukhin
author_facet V. N. Soboleva
E. O. Taratukhin
author_sort V. N. Soboleva
collection DOAJ
description The review takes into consideration the novel data on heart failure treatment: application of mineralocorticoid antagonists. The pathogenetic points are highlighted that are proved by clinical trials, as epidemiological concerns. Further opportunites are sketched for this special kind of treatment by the growth of receptor interaction selectiveness.
first_indexed 2024-04-09T20:50:24Z
format Article
id doaj.art-dd591152d59a40939af020e6f076b4f4
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2025-03-14T09:31:31Z
publishDate 2015-01-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-dd591152d59a40939af020e6f076b4f42025-03-02T11:42:35Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202015-01-010110410610.15829/1560-4071-2015-1-104-106212MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENTV. N. Soboleva0E. O. Taratukhin1SBEI HPE RNRMU n. a.N.I.Pirogov, Moscow, RussiaSBEI HPE RNRMU n. a.N.I.Pirogov, Moscow, RussiaThe review takes into consideration the novel data on heart failure treatment: application of mineralocorticoid antagonists. The pathogenetic points are highlighted that are proved by clinical trials, as epidemiological concerns. Further opportunites are sketched for this special kind of treatment by the growth of receptor interaction selectiveness.https://russjcardiol.elpub.ru/jour/article/view/212aldosteronemineralocorticoidscardiovascular mortalitymyocardial infarctioneplerenonespironolactone
spellingShingle V. N. Soboleva
E. O. Taratukhin
MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
Российский кардиологический журнал
aldosterone
mineralocorticoids
cardiovascular mortality
myocardial infarction
eplerenone
spironolactone
title MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
title_full MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
title_fullStr MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
title_full_unstemmed MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
title_short MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
title_sort mineralocorticoid antagonism selectiveness gives more opportunities for heart failure management
topic aldosterone
mineralocorticoids
cardiovascular mortality
myocardial infarction
eplerenone
spironolactone
url https://russjcardiol.elpub.ru/jour/article/view/212
work_keys_str_mv AT vnsoboleva mineralocorticoidantagonismselectivenessgivesmoreopportunitiesforheartfailuremanagement
AT eotaratukhin mineralocorticoidantagonismselectivenessgivesmoreopportunitiesforheartfailuremanagement